Abingdon Health Plc (ABDX.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ABDX.L in your mock portfolio yet.
The company is currently loss-making, as indicated by its negative EPS and negative P/E ratio. This suggests that, despite any revenue it may be generating, profitability remains elusive and the market is valuing the stock on expectations rather than current earnings power.
The stock trades at $11.00, up 4.8% over the last month, showing short-term positive momentum. Trading above its 200-day moving average of $8.72 signals a constructive intermediate trend, but this strength is not yet backed by solid fundamentals.
Social media traction appears limited and largely stagnant, with very small follower bases across platforms and minimal growth. This weak digital footprint suggests low retail investor attention and modest brand or product engagement momentum.
Overall, the setup appears bearish: the stock shows some technical strength above its 200-day moving average, but this is not supported by profitability or strong alternative data signals. The combination of negative earnings, a speculative valuation profile, and weak audience growth suggests that recent price gains may be fragile.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started